MedTrace Logo

Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion

NCT00408915 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-03-07

No results posted yet for this study

Summary

The aim of the study is to evaluate the long-term efficacy, local tolerability and safety of Lisuride applied as subcutaneous infusion compared to placebo in patients with advanced Parkinson's disease with motor fluctuations and "OFF" periods refractory to conventional treatment.

Conditions

Interventions

DRUG

Continuous Subcutaneous Lisuride Infusion

Sponsors & Collaborators

  • Axxonis Pharma AG

    lead INDUSTRY

Principal Investigators

  • J. Winkler, Professor · Klinik und Poliklinik für Neurologie der Universität Regensburg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00408915 on ClinicalTrials.gov